Epsilon-Viniferin (Grape Resveratrol Dimer)
Epsilon-viniferin is a plant compound made of two resveratrol units joined together, a type of molecule called an oligostilbene (a resveratrol dimer). It builds up mainly in the woody parts of the grapevine, such as the stems and shoots, and is also found in some other plants, so grape-stem extracts are the usual supplement source. Almost all of the research is laboratory and animal work: in cell and rodent studies it scavenges free radicals, lowers reactive oxygen species, switches on the energy sensor AMPK and supports mitochondria, and in grape-stem products it sits alongside resveratrol. There are essentially no human trials testing whether it does anything once swallowed, and the one human study that measured it could not detect any in the blood or urine, a sign of very low oral absorption. It is a separate compound from resveratrol and from grape polyphenols, each of which has its own page.
Benefits
Free radical scavenging and lower oxidative stress in laboratory studies
In test-tube assays epsilon-viniferin neutralizes DPPH free radicals, though less strongly than vitamin E. In cultured cells, including nerve and skin cells placed under stress, it lowers reactive oxygen species and helps protect the cell's energy machinery. These are laboratory measures, not results from people, and the relevance to the body is unknown.
Mitochondrial energy production in cell studies
In cell studies epsilon-viniferin activates AMP-activated protein kinase (AMPK), a cellular energy sensor, and raises levels of the mitochondrial protein SIRT3. In stressed nerve cells this went along with more ATP, a steadier mitochondrial membrane and signs of new mitochondria forming. All of this is laboratory work in cells rather than in people.
Blood sugar and blood lipid measures in animal studies
When given by mouth to diabetic rats fed a high-fat diet, epsilon-viniferin was followed by lower fasting blood sugar, total cholesterol, triglycerides and LDL cholesterol, plus better glucose handling, changes the researchers linked to AMPK activation in the liver. This is rodent work over several weeks and has not been tested in people.
Fat cell development and fat storage in preclinical models
In fat cells grown in the laboratory and in mice, epsilon-viniferin has been reported to curb the formation of new fat cells and reduce fat accumulation. Reviews describe this work as promising but preliminary and call for the animal findings to be confirmed and then tested in people. No human data exist for this effect.
Cellular aging markers in laboratory cell studies
In a laboratory study of human skin fibroblasts, epsilon-viniferin lowered the reactive oxygen species made by mitochondria and selectively cleared cells that had entered a worn-out senescent state, restoring some markers of mitochondrial function. This was a single in-cell study with no equivalent testing in people.
Mechanism of action
Activates the energy sensor AMPK
In cells and in rodents, epsilon-viniferin switches on AMP-activated protein kinase (AMPK), a master sensor that cells use to balance energy. AMPK activation is the pathway researchers most often link to its reported effects on fat storage and on blood sugar and lipid measures in animals.
Supports mitochondria through SIRT3
Laboratory work shows epsilon-viniferin raises SIRT3, a protein inside mitochondria that helps manage energy use and oxidative balance. Through SIRT3 it appears to steady the mitochondrial membrane, support the making of new mitochondria and lower reactive oxygen species in stressed cells.
Direct free-radical scavenging
As a stilbene built from two resveratrol units, epsilon-viniferin carries several phenol groups that can donate hydrogen atoms to neutralize free radicals. This is measurable in simple chemical tests such as the DPPH assay, where its activity is weaker than that of vitamin E.
Low oral absorption and rapid handling
Epsilon-viniferin is poorly absorbed when swallowed. In the one human study that looked, none could be detected in blood or urine after an oral dose, and laboratory gut-cell models agree that very little crosses the gut wall. This is a major reason its laboratory effects may not carry over to people.
Clinical trials
Laboratory study screening stilbene compounds in cultured cells that carry a disease-linked mutant protein, testing effects on SIRT3, AMPK and mitochondria. (Fu et al. 2012, J Biol Chem)
Cultured cells; no people or whole animals were dosed.
Among 22 stilbenes screened, trans-epsilon-viniferin raised mitochondrial SIRT3, activated AMPK, increased signs of new mitochondria forming, lowered reactive oxygen species and preserved mitochondrial membrane potential. Blocking SIRT3 removed these effects. A cell study only, with no human or whole-animal data.
Laboratory study in human-derived SH-SY5Y nerve-type cells stressed with rotenone, testing the SIRT3 to FOXO3 pathway. (Zhang et al. 2020, Neural Regen Res)
Cultured human-derived nerve cells; no people were studied.
Epsilon-viniferin (1 micromolar for 24 hours) raised SIRT3, increased ATP production, lowered reactive oxygen species, steadied the mitochondrial membrane and reduced cell death. Silencing SIRT3 or FOXO3 reversed the effects. A single cell-model study, not evidence in people.
Animal study giving oral epsilon-viniferin to diabetic rats (high-fat diet plus streptozotocin) for 8 weeks, with AMPK measured in the liver. (Liu et al. 2020, Food Funct)
Laboratory rats with diet- and streptozotocin-induced type 2 diabetes; no human participants.
Oral epsilon-viniferin at 30 and 60 mg/kg was followed by lower fasting blood sugar, total cholesterol, triglycerides and LDL cholesterol, better glucose tolerance and higher AMPK activation in the liver, with liver and kidney blood markers also improved. An 8-week rat study; the results have not been reproduced in people.
Laboratory screen of plant compounds for control of mitochondrial reactive oxygen species in cultured human fibroblasts. (Park et al. 2025, Pharmaceuticals (Basel))
Cultured human skin fibroblasts; in vitro only.
Epsilon-viniferin lowered mitochondrial reactive oxygen species, acted as a senolytic that selectively removed worn-out senescent cells and restored some mitochondrial function, with the gene RGS16 identified as a mediator. An in-cell study with no human or animal testing.
Randomized single-dose crossover pharmacokinetic study in healthy volunteers comparing native and micellar grapevine-shoot extract. (Calvo-Castro et al. 2018, Mol Nutr Food Res)
12 healthy adults (6 women and 6 men).
After a single 500 mg dose of grapevine-shoot extract (supplying about 75 mg trans-epsilon-viniferin and 30 mg trans-resveratrol), no trans-epsilon-viniferin could be detected in blood or urine over 24 hours, while resveratrol absorption improved with a micellar form. No treatment-related adverse effects were reported. This measured absorption and safety, not any health outcome.
Laboratory isolation of resveratrol-dimer isomers from grape stems with a DPPH antioxidant assay. (Kong et al. 2016, J Sep Sci)
Chemical assay; no cells, animals or people.
Purified trans-epsilon-viniferin scavenged DPPH free radicals, but less strongly than its isomer trans-delta-viniferin, which in turn was slightly weaker than vitamin E at the same concentration. A test-tube antioxidant measure only.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Epsilon-Viniferin (Grape Resveratrol Dimer)
Is epsilon-viniferin the same as resveratrol?
No. Epsilon-viniferin is a dimer, meaning two resveratrol molecules joined together, which makes it a larger and different compound called an oligostilbene. Grapevines build it mainly in their woody stems. We keep it on its own page, separate from resveratrol and from grape polyphenols, because its evidence is very different.
Does epsilon-viniferin work in people?
There is essentially no human evidence. Almost all of the research is in test tubes and animals, where it scavenges free radicals and switches on the energy sensor AMPK. The one human study that measured it could not find any in the blood or urine after an oral dose, which suggests very little is absorbed. Treat any benefit as unproven in people.
How is it different from grape polyphenols or grape seed extract?
Grape polyphenols and grape seed extracts are mixtures of many compounds, such as anthocyanins, flavanols and resveratrol. Epsilon-viniferin is one single compound, a resveratrol dimer concentrated in grapevine stems. Those grape products have their own pages and their own, mostly small, human studies; this page is about the single compound, which has none.
How much do people take?
There is no established human dose. Animal studies used about 30 to 60 mg per kg of body weight by mouth, and a human absorption study used a single 500 mg grapevine-shoot extract that supplied roughly 75 mg of epsilon-viniferin. Because so little is absorbed and no efficacy trials exist, follow the product label and talk to a doctor.
What is Epsilon-Viniferin?
Epsilon-viniferin is a plant compound made of two resveratrol units joined together, a type of molecule called an oligostilbene (a resveratrol dimer). It builds up mainly in the woody parts of the grapevine, such as the stems and shoots, and is also found in some other plants, so grape-stem extracts are the usual suppl…
What is Epsilon-Viniferin used for?
Epsilon-Viniferin is researched primarily for Antioxidant. In test-tube assays epsilon-viniferin neutralizes DPPH free radicals, though less strongly than vitamin E. In cultured cells, including nerve and skin cells placed under stress, it lowers reactive oxygen species and helps protect the cell's…
Is Epsilon-Viniferin safe, and does it have side effects?
Side effects and cautions reported for Epsilon-Viniferin include: Human safety data are very limited. In the only human study, a single 500 mg dose of a grapevine-shoot extract supplying about 75 mg epsilon-viniferin caused no treatment-related adverse effects, but that was one dose in 12 people. Oral absorption is very low. It may also interact with some medications. Epsilon-Viniferin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.
Does Epsilon-Viniferin interact with any medications?
Possible interactions include: No drug interaction studies of epsilon-viniferin in people have been published. Because it is a close relative of resveratrol and is usually taken in extracts that also contain resveratrol, any interactions reported for resveratrol could in principle apply; resveratrol may affect… If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Epsilon-Viniferin?
NutraSmarts rates the evidence for Epsilon-Viniferin as Preliminary (1 out of 5). It is backed by 6 study summaries and 8 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(8 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- trans-(-)-ε-Viniferin increases mitochondrial sirtuin 3 (SIRT3), activates AMP-activated protein kinase (AMPK), and protects cells in models of Huntington Disease. J Biol Chem. 2012;287(29):24460-72. doi: 10.1074/jbc.M112.382226.PubMedUsed to support: Cell study: among 22 stilbenes, trans-epsilon-viniferin raised mitochondrial SIRT3, activated AMPK, promoted mitochondrial biogenesis, lowered reactive oxygen species and preserved membrane potential; blocking SIRT3 abolished the effect. In vitro evidence only.
- Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation. Neural Regen Res. 2020;15(11):2143-2153. doi: 10.4103/1673-5374.282264.PubMedUsed to support: Cell study in stressed human-derived nerve cells: epsilon-viniferin raised SIRT3, increased ATP, lowered reactive oxygen species and reduced cell death through the SIRT3 to FOXO3 pathway; silencing those genes reversed it. Laboratory evidence only.
- ε-Viniferin, a promising natural oligostilbene, ameliorates hyperglycemia and hyperlipidemia by activating AMPK in vivo. Food Funct. 2020;11(11):10084-10093. doi: 10.1039/d0fo01932a.PubMedUsed to support: Animal study in rats on a high-fat diet: 8 weeks of oral epsilon-viniferin (30 and 60 mg/kg) lowered fasting blood sugar and blood lipids and raised AMPK activation in the liver. Rodent evidence only.
- ε-Viniferin Rejuvenates Senescence via RGS16 Regulation: In Vitro Evidence. Pharmaceuticals (Basel). 2025;18(9):1254. doi: 10.3390/ph18091254.PubMedUsed to support: In vitro study in human fibroblasts: epsilon-viniferin lowered mitochondrial reactive oxygen species and selectively cleared senescent cells, with RGS16 identified as a mediator. Cell-model evidence only.
- The Oral Bioavailability of Trans-Resveratrol from a Grapevine-Shoot Extract in Healthy Humans is Significantly Increased by Micellar Solubilization. Mol Nutr Food Res. 2018;62(9):e1701057. doi: 10.1002/mnfr.201701057.PubMedUsed to support: Human single-dose crossover pharmacokinetic study in 12 healthy adults: after 500 mg grapevine-shoot extract (about 75 mg trans-epsilon-viniferin), no epsilon-viniferin was detectable in blood or urine, while resveratrol absorption rose with a micellar form; no treatment-related adverse effects. Measured absorption and safety, not efficacy.
- Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations. Nutrients. 2023;15(4):928. doi: 10.3390/nu15040928.PubMedUsed to support: Review of laboratory and animal work: in fat cells and in mice, epsilon-viniferin reduced fat accumulation and related changes, but it is poorly absorbed orally and the authors stress that human studies are still needed. No human efficacy data.
- Toxicological Evaluation of Piceatannol, Pterostilbene, and ε-Viniferin for Their Potential Use in the Food Industry: A Review. Foods. 2021;10(3):592. doi: 10.3390/foods10030592.PubMedUsed to support: Toxicology review of three stilbenes including epsilon-viniferin: documents cytotoxicity in cultured cells and some reports of DNA damage, notes no standard EFSA genotoxicity testing and no in vivo toxicity studies, and concludes more safety data are needed.
- Isolation and purification of two antioxidant isomers of resveratrol dimer from the wine grape by counter-current chromatography. J Sep Sci. 2016;39(12):2374-9. doi: 10.1002/jssc.201600004.PubMedUsed to support: Laboratory isolation paper with a DPPH assay: purified trans-epsilon-viniferin scavenged free radicals but less strongly than its isomer trans-delta-viniferin, which was slightly weaker than vitamin E. Test-tube antioxidant measure only.